Inositol

What the evidence actually shows

Inositol is a B-vitamin-like compound that plays a central role in cellular signalling, particularly in pathways involved in insulin sensitivity and reproductive hormones. The strongest current evidence supports its use in polycystic ovary syndrome (PCOS) — with multiple trials showing improvements in ovulation frequency, menstrual regularity, insulin sensitivity, androgen levels, and metabolic markers.

The evidence is good for reductions in anxiety symptoms (particularly in panic disorder and obsessive-compulsive disorder, where high-dose myo-inositol has shown effects comparable to standard medications in some trials), improvements in glycemic control in pre-diabetes and gestational diabetes, modest reductions in blood pressure, improvements in lipid profile (lower LDL and triglycerides), modest weight and BMI reductions in metabolic syndrome, and reductions in testosterone in women with hyperandrogenism.

What inositol does poorly is produce a fast effect. PCOS and metabolic improvements typically require 12 weeks of consistent use; mood and anxiety effects can take 4–8 weeks. There is no meaningful single-dose action.

The two main forms — myo-inositol and D-chiro-inositol — have different evidence patterns. Myo-inositol predominates in most ovulation and metabolic trials; D-chiro-inositol is studied for androgen-related effects; the 40:1 myo:D-chiro ratio mirrors the body's natural plasma ratio and is what most current PCOS research uses.

How it works

Inositol exists in the body in nine isomeric forms, with myo-inositol being the most abundant. It is a precursor to inositol phosphoglycans (IPGs), which are second messengers in the insulin signalling pathway and in the receptor signalling for several pituitary hormones (LH, FSH, TSH).

In PCOS, the underlying defect appears to be a disturbed metabolism of inositol — leading to insulin resistance, hyperandrogenism, and disrupted ovulation. Supplementation appears to restore IPG availability, normalising insulin signalling and reducing androgen production.

Inositol is also concentrated in brain tissue, where it plays a role in serotonin receptor signalling. This is the mechanistic basis for its anxiolytic and antidepressant effects — though the doses needed for mood effects (typically 12–18 g/day) are much higher than for metabolic effects (2–4 g/day).

The dose differences across conditions reflect different mechanisms — peripheral metabolic effects respond to lower doses than central nervous system effects.

Who benefits most — and who should be cautious

The clearest beneficiaries are women with PCOS (particularly those with insulin resistance and irregular menstrual cycles), women undergoing fertility treatment with PCOS-related ovulatory dysfunction, adults with metabolic syndrome or pre-diabetes wanting an insulin-sensitising adjunct, and people with panic disorder or moderate anxiety wanting a high-dose option with a different mechanism than SSRIs.

The case is weaker for healthy adults without metabolic or hormonal concerns.

The main cautions are dose-related gastrointestinal effects and interactions. At PCOS doses (2–4 g/day) inositol is well tolerated. At anxiolytic doses (12–18 g/day) gastrointestinal symptoms (nausea, gas, diarrhoea) become common — slow titration helps.

Inositol can lower blood sugar, relevant for people on insulin or oral diabetes medications. It also has mild blood-pressure-lowering effects. No major drug interactions are well documented at standard doses.

Inositol is one of the more well-studied supplements in pregnancy — particularly for prevention of gestational diabetes and neural tube defects — but high-dose use in pregnancy should still be discussed with a clinician.

How to take it

Form.

• Myo-inositol for general PCOS, metabolic, and mood effects
• 40:1 myo-inositol to D-chiro-inositol ratio for PCOS specifically (mirrors physiological ratio)
• D-chiro-inositol alone is generally not recommended outside specialist guidance

Dose.

• PCOS and metabolic support: 2–4 g/day of myo-inositol, divided in two
• Anxiety and panic disorder: 12–18 g/day, divided across the day (titrate up slowly)
• Pre-diabetes and glycemic support: 2 g/day
• Gestational diabetes prevention (under medical guidance): 2 g/day

Timing. With or without food. The powder dissolves easily in water and is mildly sweet.

Be patient. PCOS effects emerge over 12 weeks. Anxiety effects emerge over 4–8 weeks at high doses.

Common misconceptions

Inositol is a vitamin. It is a sugar alcohol that the body can synthesise, so it does not meet the strict definition of a vitamin — though it is sometimes labelled as "vitamin B8" in older literature.

The 40:1 ratio is marketing. It mirrors the natural plasma ratio of myo to D-chiro inositol in healthy women and is what most current PCOS research uses. The rationale is biological, not marketing.

Higher doses always work better for PCOS. They do not. Above 4–5 g/day of myo-inositol for PCOS, additional benefit is small while side effects (gastrointestinal symptoms) increase.

It works as fast as antidepressants for anxiety. It does not. High-dose inositol may match SSRIs in some trials but the onset of effect is similar (4–8 weeks), not faster.

All inositol supplements are equivalent. They differ substantially in form and ratio. For PCOS specifically, look for products specifying the 40:1 myo:D-chiro ratio.

FAQ

How long until I notice effects? For PCOS and ovulation: 12 weeks. For anxiety: 4–8 weeks at high doses. For glycemic markers: 8–12 weeks.

Should I take it with metformin? Often used together for PCOS, with apparently additive effects in some trials. Discuss with your prescriber.

Can men take inositol? Yes, particularly for metabolic syndrome, glycaemic markers, and anxiety. PCOS-specific use is, by definition, for women.

Does it interact with medications? With insulin and oral diabetes medications (can lower blood sugar), and minor interactions with some psychiatric medications. Mention regular inositol use to your prescriber.

Is it safe in pregnancy? Standard PCOS doses (2–4 g/day) are generally considered safe and have some evidence of benefit for gestational diabetes prevention. High doses (above 4 g/day) should be discussed with a clinician.

Evidence grades and benefit rankings on this page are sourced from Examine.com, an independent research database with no industry funding.